Analyst Research

Report Title Price
Provider : Reuters Investment Profile
$20.00
Provider : GlobalData
$125.00
Provider : GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Xvivo Perfusion AB receives market approval from FDA for Steen Solution and XPS


Wednesday, 13 Aug 2014 02:30am EDT 

XvivoPerfusion AB:Receives market approval from the FDA for steen Solution(TM) and Xps(TM). 

Company Quote

49.9
1.9 +3.96%
4 Sep 2015